Fwd: [URGENT] [REMINDER]: IN–AUS CECA Meeting on PSR Mandates
Rajat Kapoor (ADMI-Secretariat)
Dear Members,
With reference to the email received from the Department of Pharmaceuticals (DoP) regarding queries raised by the Australian side on the proposed Product Specific Rules (PSRs) for certain medical device tariff lines, please find attached the relevant communication along with the Excel sheet for providing tariff line-wise comments/inputs.
The matter is likely to be discussed during the forthcoming intersessional meeting, and the Department has requested comments from industry stakeholders on an urgent basis.
Members are requested to kindly review the enclosed Excel sheet and share their inputs/comments at the eralies possible.
Your prompt support and technical feedback will be highly appreciated.
Regards,
 | Rajat Kapoor
|
From: Ananya Mamgaain <yp2-inte...@pharma-dept-consultant.gov.in>
Date: Wed, May 13, 2026 at 1:23 PM
Subject: [URGENT] [REMINDER]: IN–AUS CECA Meeting on PSR Mandates
To: Rajat Kapoor (ADMI-Secretariat) <secre...@admi-india.org>
Cc: US MedicalDevices <us-medic...@pharma-dept.gov.in>, Shivani Kaur <so-medic...@pharma-dept.gov.in>, edepcmd <ed.e...@yamunaexpresswayauthority.com>, praveenmittal <praveen...@epcmd.in>, sankalpbhatia <sankalp...@epcmd.in>, shubhankarb <shubha...@epcmd.in>, ravigautam <ravi....@epcmd.in>, Mr. Thomas John <pres...@admi-india.org>, rakeshbhatia <rakesh...@aimedindia.com>, forumcoordinator <forumcoo...@aimedindia.com>, jtcoordinatorivd <jt.coordi...@aimedindia.com>, Aman Sharma <head-medi...@pharma-dept.gov.in>, Vishal V Nair <head-intern...@pharma-dept.gov.in>, Hitendra Sahu <divhead-med...@pharma-dept.gov.in>, Hitendra Sahu <divhead-inte...@pharma-dept.gov.in>, Giriraj Prasad Meena <us-interna...@pharma-dept.gov.in>, Ekta Barkhodia <so-interna...@pharma-dept.gov.in>, Anidhya <yp1-inte...@pharma-dept-contractor.gov.in>
To: "Ananya Mamgaain"<yp2-inte...@pharma-dept-consultant.gov.in>
Cc: "US MedicalDevices"<us-medic...@pharma-dept.gov.in>, "Shivani Kaur"<so-medic...@pharma-dept.gov.in>, "edepcmd"<ed.e...@yamunaexpresswayauthority.com>, "praveenmittal"<praveen...@epcmd.in>, "sankalpbhatia"<sankalp...@epcmd.in>, "shubhankarb"<shubha...@epcmd.in>, "ravigautam"<ravi....@epcmd.in>, "Mr. Thomas John"<pres...@admi-india.org>, "rakeshbhatia"<rakesh...@aimedindia.com>, "forumcoordinator"<forumcoo...@aimedindia.com>, "jtcoordinatorivd"<jt.coordi...@aimedindia.com>, "Aman Sharma"<head-medi...@pharma-dept.gov.in>, "Vishal V Nair"<head-intern...@pharma-dept.gov.in>, "Hitendra Sahu"<divhead-med...@pharma-dept.gov.in>, "Hitendra Sahu"<divhead-inte...@pharma-dept.gov.in>, "Giriraj Prasad Meena"<us-interna...@pharma-dept.gov.in>, "Ekta Barkhodia"<so-interna...@pharma-dept.gov.in>, "Anidhya"<yp1-inte...@pharma-dept-contractor.gov.in>
Date: Wed, 13 May 2026 11:54:20 +0530
Subject: Re: [URGENT] [REMINDER]: IN–AUS CECA Meeting on PSR Mandates
Dear Madam,
The Excel sheet is missing. Kindly share the same.
Best Regards,
Rajat Kapoor
With reference to the trailing email on the above-mentioned subject, the MedTech Policy Division of the Department, EPCMD, and medical devices associations/stakeholders are requested to furnish their inputs/comments against each tariff line in the enclosed Excel sheet.
2. The same may kindly be shared with the Department on an urgent basis, latest by 12:00 noon today.
Regards,
Ananya Mamgaain
Young Professional (International Cooperation Division)
Department of Pharmaceuticals
Ministry of Chemicals and Fertilizers
Government of India
Janpath Bhawan, New Delhi - 110 001
From: Ananya Mamgaain <yp2-inte...@pharma-dept-consultant.gov.in>
To: "US MedicalDevices"<us-medic...@pharma-dept.gov.in>, "Shivani Kaur"<so-medic...@pharma-dept.gov.in>, "edepcmd"<ed.e...@yamunaexpresswayauthority.com>, "praveenmittal"<praveen...@epcmd.in>, "sankalpbhatia"<sankalp...@epcmd.in>, "shubhankarb"<shubha...@epcmd.in>, "ravigautam"<ravi....@epcmd.in>, "secretariat"<secre...@admi-india.org>, "Mr. Thomas John"<pres...@admi-india.org>, "rakeshbhatia"<rakesh...@aimedindia.com>, "forumcoordinator"<forumcoo...@aimedindia.com>, "jtcoordinatorivd"<jt.coordi...@aimedindia.com>
Cc: "Aman Sharma"<head-medi...@pharma-dept.gov.in>, "Vishal V Nair"<head-intern...@pharma-dept.gov.in>, "Hitendra Sahu"<divhead-med...@pharma-dept.gov.in>, "Hitendra Sahu"<divhead-inte...@pharma-dept.gov.in>, "Giriraj Prasad Meena"<us-interna...@pharma-dept.gov.in>, "Ekta Barkhodia"<so-interna...@pharma-dept.gov.in>, "Anidhya"<yp1-inte...@pharma-dept-contractor.gov.in>
Date: Fri, 08 May 2026 17:32:40 +0530
Subject: IN–AUS CECA Meeting on PSR MandatesSir/Madam,
With reference to the subject cited above, the undersigned is directed to inform that the Australian side has raised the following query regarding the Product Specific Rules (PSRs) proposed by the Department of Pharmaceuticals for the enclosed medical device tariff lines, which are likely to be discussed during the forthcoming intersessional meeting:
a. "Noting the subheadings are distinct goods, grateful if India can advise where the subheading level movement is occurring here that would require a PSR of CTSH?"b. "There are no subheadings in this heading making the use of CTSH redundant and placing additional administrative burden on traders for no reason."2. In this regard, the MedTech Policy Division of the Department, EPCMD and medical devices associations/stakeholders are requested to furnish their inputs/comments against each tariff line in the enclosed Excel sheet and share the same with the Department at the earliest.Regards,
Ananya Mamgaain
Young Professional (International Cooperation Division)
Department of Pharmaceuticals
Ministry of Chemicals and Fertilizers
Government of India
Janpath Bhawan, New Delhi - 110 001